Logo image of CCEL

CRYO-CELL INTL INC (CCEL) Stock Fundamental Analysis

NYSEARCA:CCEL - NYSE Arca - US2288951088 - Common Stock - Currency: USD

5.515  -0.11 (-1.87%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CCEL. CCEL was compared to 102 industry peers in the Health Care Providers & Services industry. While CCEL is still in line with the averages on profitability rating, there are concerns on its financial health. CCEL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

CCEL had positive earnings in the past year.
In the past year CCEL had a positive cash flow from operations.
Of the past 5 years CCEL 4 years were profitable.
Each year in the past 5 years CCEL had a positive operating cash flow.
CCEL Yearly Net Income VS EBIT VS OCF VS FCFCCEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

The Return On Assets of CCEL (0.20%) is comparable to the rest of the industry.
With a decent Return On Invested Capital value of 7.45%, CCEL is doing good in the industry, outperforming 70.59% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CCEL is in line with the industry average of 9.13%.
Industry RankSector Rank
ROA 0.2%
ROE N/A
ROIC 7.45%
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
CCEL Yearly ROA, ROE, ROICCCEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1.3 Margins

CCEL has a Profit Margin (0.40%) which is in line with its industry peers.
In the last couple of years the Profit Margin of CCEL has declined.
CCEL has a Operating Margin of 12.53%. This is amongst the best in the industry. CCEL outperforms 84.31% of its industry peers.
In the last couple of years the Operating Margin of CCEL has declined.
CCEL's Gross Margin of 75.79% is amongst the best of the industry. CCEL outperforms 90.20% of its industry peers.
In the last couple of years the Gross Margin of CCEL has grown nicely.
Industry RankSector Rank
OM 12.53%
PM (TTM) 0.4%
GM 75.79%
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
CCEL Yearly Profit, Operating, Gross MarginsCCEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CCEL is destroying value.
Compared to 1 year ago, CCEL has less shares outstanding
Compared to 5 years ago, CCEL has more shares outstanding
The debt/assets ratio for CCEL has been reduced compared to a year ago.
CCEL Yearly Shares OutstandingCCEL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CCEL Yearly Total Debt VS Total AssetsCCEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of 0.12, we must say that CCEL is in the distress zone and has some risk of bankruptcy.
CCEL has a worse Altman-Z score (0.12) than 77.45% of its industry peers.
CCEL has a debt to FCF ratio of 1.59. This is a very positive value and a sign of high solvency as it would only need 1.59 years to pay back of all of its debts.
The Debt to FCF ratio of CCEL (1.59) is better than 86.27% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.59
Altman-Z 0.12
ROIC/WACC0.71
WACC10.43%
CCEL Yearly LT Debt VS Equity VS FCFCCEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

2.3 Liquidity

A Current Ratio of 0.58 indicates that CCEL may have some problems paying its short term obligations.
With a Current ratio value of 0.58, CCEL is not doing good in the industry: 89.22% of the companies in the same industry are doing better.
CCEL has a Quick Ratio of 0.58. This is a bad value and indicates that CCEL is not financially healthy enough and could expect problems in meeting its short term obligations.
CCEL has a worse Quick ratio (0.54) than 86.27% of its industry peers.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.54
CCEL Yearly Current Assets VS Current LiabilitesCCEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 101.72% over the past year.
Measured over the past years, CCEL shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -29.04% on average per year.
The Revenue has been growing slightly by 2.33% in the past year.
The Revenue has been growing slightly by 0.11% on average over the past years.
EPS 1Y (TTM)101.72%
EPS 3Y-41.85%
EPS 5Y-29.04%
EPS Q2Q%-57.14%
Revenue 1Y (TTM)2.33%
Revenue growth 3Y3.46%
Revenue growth 5Y0.11%
Sales Q2Q%1.49%

3.2 Future

CCEL is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -68.82% yearly.
CCEL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.77% yearly.
EPS Next Y-304%
EPS Next 2Y-68.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.59%
Revenue Next 2Y0.77%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CCEL Yearly Revenue VS EstimatesCCEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
CCEL Yearly EPS VS EstimatesCCEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 -0.5 -1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

CCEL is valuated quite expensively with a Price/Earnings ratio of 275.75.
60.78% of the companies in the same industry are cheaper than CCEL, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CCEL to the average of the S&P500 Index (28.87), we can say CCEL is valued expensively.
CCEL is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 275.75
Fwd PE N/A
CCEL Price Earnings VS Forward Price EarningsCCEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 200

4.2 Price Multiples

72.55% of the companies in the same industry are more expensive than CCEL, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CCEL is valued cheaply inside the industry as 88.24% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.39
EV/EBITDA 9.49
CCEL Per share dataCCEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

CCEL's earnings are expected to decrease with -68.82% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.82%
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

CCEL has a Yearly Dividend Yield of 17.45%, which is a nice return.
The stock price of CCEL dropped by -29.20% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
CCEL's Dividend Yield is rather good when compared to the industry average which is at 2.58. CCEL pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.46, CCEL pays a better dividend.
Industry RankSector Rank
Dividend Yield 17.45%

5.2 History

CCEL has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CCEL Yearly Dividends per shareCCEL Yearly Dividends per shareYearly Dividends per share 2022 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

3137.42% of the earnings are spent on dividend by CCEL. This is not a sustainable payout ratio.
DP3137.42%
EPS Next 2Y-68.82%
EPS Next 3YN/A
CCEL Yearly Income VS Free CF VS DividendCCEL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M
CCEL Dividend Payout.CCEL Dividend Payout, showing the Payout Ratio.CCEL Dividend Payout.PayoutRetained Earnings

More info and screens

CRYO-CELL INTL INC

NYSEARCA:CCEL (4/28/2025, 8:04:01 PM)

5.515

-0.11 (-1.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)04-14 2025-04-14/amc
Earnings (Next)07-14 2025-07-14/amc
Inst Owners7.71%
Inst Owner Change-1.4%
Ins Owners40.27%
Ins Owner Change1.01%
Market Cap44.56M
Analysts82.86
Price Target8.67 (57.21%)
Short Float %0.14%
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield 17.45%
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP3137.42%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-14 2025-02-14 (0.25)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.21%
Min Revenue beat(2)-1.52%
Max Revenue beat(2)-0.9%
Revenue beat(4)0
Avg Revenue beat(4)-1.19%
Min Revenue beat(4)-1.52%
Max Revenue beat(4)-0.9%
Revenue beat(8)0
Avg Revenue beat(8)-1.59%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.56%
PT rev (3m)-5.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-250%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.69%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)-0.32%
Valuation
Industry RankSector Rank
PE 275.75
Fwd PE N/A
P/S 1.39
P/FCF 8.39
P/OCF 6.09
P/B N/A
P/tB N/A
EV/EBITDA 9.49
EPS(TTM)0.02
EY0.36%
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)0.66
FCFY11.92%
OCF(TTM)0.91
OCFY16.43%
SpS3.97
BVpS-1.81
TBVpS-2.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.2%
ROE N/A
ROCE 9.43%
ROIC 7.45%
ROICexc 8.11%
ROICexgc 8.75%
OM 12.53%
PM (TTM) 0.4%
GM 75.79%
FCFM 16.55%
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
ROICexc(3y)7.98%
ROICexc(5y)14.72%
ROICexgc(3y)8.63%
ROICexgc(5y)16.85%
ROCE(3y)9.64%
ROCE(5y)14.41%
ROICexcg growth 3Y-17.95%
ROICexcg growth 5Y-25.17%
ROICexc growth 3Y-16.74%
ROICexc growth 5Y-23.68%
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
F-Score8
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.59
Debt/EBITDA 1.7
Cap/Depr 234.65%
Cap/Sales 6.26%
Interest Coverage 1.99
Cash Conversion 150.07%
Profit Quality 4125.62%
Current Ratio 0.58
Quick Ratio 0.54
Altman-Z 0.12
F-Score8
WACC10.43%
ROIC/WACC0.71
Cap/Depr(3y)548.95%
Cap/Depr(5y)370.25%
Cap/Sales(3y)23.15%
Cap/Sales(5y)15.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.72%
EPS 3Y-41.85%
EPS 5Y-29.04%
EPS Q2Q%-57.14%
EPS Next Y-304%
EPS Next 2Y-68.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.33%
Revenue growth 3Y3.46%
Revenue growth 5Y0.11%
Sales Q2Q%1.49%
Revenue Next Year0.59%
Revenue Next 2Y0.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.34%
EBIT growth 3Y-9.92%
EBIT growth 5Y-12.52%
EBIT Next Year-18.12%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y266.76%
FCF growth 3Y-15.98%
FCF growth 5Y-8.62%
OCF growth 1Y-15.93%
OCF growth 3Y-8.81%
OCF growth 5Y-1.01%